Temperatures are set to rise to double figures on Monday as the country’s bitter cold snap comes to an end – and the thaw could lead to some flooding. As temperatures move above 0C, ice and snow will ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer (NSCLC) but is also ...